Prevalence of estimated GFR reporting among US clinical laboratories.
Prevalence of estimated GFR reporting among US clinical laboratories.
复制标题
DOI:
10.1053/j.ajkd.2008.05.023
复制
发表时间:
2008-10
期刊:
影响因子:
--
通讯作者:
Narva AS
中科院分区:
文献类型:
--
作者:
Accetta NA;Gladstone EH;DiSogra C;Wright EC;Briggs M;Narva AS
Routine laboratory reporting of estimated glomerular filtration rate (eGFR) may help clinicians detect kidney disease. The current national prevalence of eGFR reporting among clinical laboratories is unknown, thus the extent of the situation of laboratories not routinely reporting eGFR with serum creatinine (SCr) results is not quantified. Observational analysis. National Kidney Disease Education Program survey of clinical laboratory conducted in 2006-7 by mail, Web, and telephone follow up. A national random sample, 6,350 clinical laboratories, drawn from the Federal Clinical Laboratory Improvement Amendments database and stratified by six major laboratory types/groupings. Laboratory reports SCr results. Reporting eGFR values along with SCr results. Percent of laboratories reporting eGFR along with reporting SCr, reporting protocol, eGFR formula used, and style of reporting cutoff values. Among laboratories reporting SCr, 38.4% report eGFR (physician offices, 25.8%; hospitals, 43.6%; independents, 38.9%; community clinics, 47.2%; health fair/insurance/public health, 45.5%; others, 43.2%). Physician office laboratories have a reporting prevalence lower than other laboratory types (p < 0.001). Among laboratories reporting eGFR, 66.7% do so routinely with all adult SCr determinations; 71.6% use the 4-variable Modification of Diet in Renal Disease Study equation; and 45.3% use the “>60 mL/min/1.73 m2” reporting convention. Independent laboratories are least likely to routinely report eGFR, (50.6%, p < .05) and most likely to report only when specifically requested (45.4%, p < 0.05). High-volume laboratories across all strata are more likely to report eGFR (p < 0.001). Self-reporting by laboratories, Federal database did not have names of laboratory directors/managers (intended respondents), assumed accuracy of Federal database for sample purposes. Routine eGFR reporting with SCr is not yet universal and laboratories vary in their reporting practices.
登录
查看更多内容
影响因子:
2.6
作者:
Quartarolo, Jennifer M.;Thoelke, Mark;Schafers, Stephen J.
通讯作者:
Schafers, Stephen J.
影响因子:
--
作者:
Akbari, A;Swedko, PJ;Ooi, D
通讯作者:
Ooi, D
影响因子:
39.2
作者:
Levey, AS;Coresh, J;Eknoyan, G
通讯作者:
Eknoyan, G
影响因子:
11.1
作者:
Verhave, JC;Baljé-Volkers, CP;De Jong, PE
通讯作者:
De Jong, PE
影响因子:
3.7
作者:
RAO, JNK;SCOTT, AJ
通讯作者:
SCOTT, AJ